login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AKILI INC (AKLI) Stock News
USA
- NASDAQ:AKLI -
US00974B1070
-
Common Stock
0.432
USD
0 (-0.62%)
Last: 7/1/2024, 8:18:36 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AKLI Latest News, Press Relases and Analysis
All
Press Releases
a year ago - By: Akili, Inc.
Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game
a year ago - By: Halper Sadeh LLC
- Mentions:
UMBF
DPSI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates UMBF, DPSI, AKLI on Behalf of Shareholders
a year ago - By: InvestorPlace
AKLI Stock Earnings: Akili Beats EPS, Misses Revenue for Q1 2024
2 years ago - By: InvestorPlace
- Mentions:
MRIN
ST
Why Is Akili (AKLI) Stock Up 68% Today?
2 years ago - By: Benzinga
Preview: Akili's Earnings
a year ago - By: Brodsky & Smith LLC
- Mentions:
MRO
ATRI
SRDX
COP
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
a year ago - By: Halper Sadeh LLC
AKLI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akili, Inc. Is Fair to Shareholders
a year ago - By: Brodsky & Smith LLC
- Mentions:
MRO
ATRI
COP
SRDX
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Marathon Oil Corporation (NYSE – MRO), Atrion Corporation (Nasdaq – ATRI), Surmodics, Inc. (Nasdaq – SRDX), Akili, Inc. (Nasdaq – AKLI)
a year ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair Price for its Public Shareholders
a year ago - By: Virtual Therapeutics
Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company
a year ago - By: BusinessInsider
AKLI Stock Earnings: Akili Beats EPS, Misses Revenue for Q1 2024
a year ago - By: Benzinga
- Mentions:
PBM
BOLT
IRIX
PBH
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
a year ago - By: Akili, Inc.
Akili Reports First Quarter 2024 Financial Results and Provides Business Update
2 years ago - By: InvestorPlace
Why Is Akili (AKLI) Stock Up 110% Today?
2 years ago - By: InvestorPlace
- Mentions:
AGBA
AMZN
MRIN
AGBA Stock Pops 35% on Triller Merger Update
2 years ago - By: Akili, Inc.
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
2 years ago - By: InvestorPlace
- Mentions:
MRDB
PRGS
DXYZ
PAYS
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
2 years ago - By: Akili, Inc.
Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2 years ago - By: PureTech Health plc
- Mentions:
PRTC
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
2 years ago - By: Seeking Alpha
Akili's ADHD device submitted for Japanese approval, stock rallies 130% (NASDAQ:AKLI)
Please enable JavaScript to continue using this application.